Literature DB >> 12481415

Histone deacetylase inhibitors all induce p21 but differentially cause tubulin acetylation, mitotic arrest, and cytotoxicity.

Mikhail V Blagosklonny1, Robert Robey, Dan L Sackett, Litong Du, Frank Traganos, Zbigniew Darzynkiewicz, Tito Fojo, Susan E Bates.   

Abstract

By preventing deacetylation of histones, histone deacetylase inhibitors (HDIs) transcriptionally induce p21. Here we show that the HDIs sodium butyrate (Bu), trichostatin A (TSA) and depsipeptide (FR901228) all induced p21, but only TSA and FR901228 caused mitotic arrest (in addition to arrest in G1 and G2). The ability to cause mitotic arrest correlated with the higher cytotoxicity of these compounds. Although causing mitotic arrest, TSA and FR901228 (unlike paclitaxel) did not affect tubulin polymerization. Unlike FR9012208, TSA caused acetylation of tubulin at lysine 40; both soluble tubulin and microtubules were acetylated. Whereas the induction of p21 reached a maximum by 8 h, tubulin was maximally acetylated after only 1 h of TSA treatment. Tubulin acetylation was detectable after treatment with 12-25 ng/ml TSA although acetylation plateaued at 50 ng/ml TSA, coinciding with G2-M arrest, appearance of cells with a sub-2N DNA content, poly(ADP-ribose) polymerase cleavage, and rapid cell death. We conclude that HDIs have differential effects on non-histone deacetylases and that rapid acetylation of tubulin caused by TSA is a marker of nontranscriptional effects of TSA.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12481415

Source DB:  PubMed          Journal:  Mol Cancer Ther        ISSN: 1535-7163            Impact factor:   6.261


  71 in total

1.  Dual targeting of histone deacetylase and topoisomerase II with novel bifunctional inhibitors.

Authors:  William Guerrant; Vishal Patil; Joshua C Canzoneri; Adegboyega K Oyelere
Journal:  J Med Chem       Date:  2012-02-13       Impact factor: 7.446

Review 2.  Multiple roles of class I HDACs in proliferation, differentiation, and development.

Authors:  Nina Reichert; Mohamed-Amin Choukrallah; Patrick Matthias
Journal:  Cell Mol Life Sci       Date:  2012-07       Impact factor: 9.261

3.  Aggresome induction by proteasome inhibitor bortezomib and alpha-tubulin hyperacetylation by tubulin deacetylase (TDAC) inhibitor LBH589 are synergistic in myeloma cells.

Authors:  Laurence Catley; Ellen Weisberg; Tanyel Kiziltepe; Yu-Tzu Tai; Teru Hideshima; Paola Neri; Pierfrancesco Tassone; Peter Atadja; Dharminder Chauhan; Nikhil C Munshi; Kenneth C Anderson
Journal:  Blood       Date:  2006-05-25       Impact factor: 22.113

4.  Histone deacetylase inhibitor-mediated cell death is distinct from its global effect on chromatin.

Authors:  Victoria L Luchenko; Thomas Litman; Arup R Chakraborty; Aaron Heffner; Christopher Devor; Julia Wilkerson; Wilfred Stein; Robert W Robey; Lois Bangiolo; David Levens; Susan E Bates
Journal:  Mol Oncol       Date:  2014-05-28       Impact factor: 6.603

Review 5.  Evolving insights in the pathogenesis and therapy of cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome).

Authors:  Henry K Wong; Anjali Mishra; Timothy Hake; Pierluigi Porcu
Journal:  Br J Haematol       Date:  2011-08-25       Impact factor: 6.998

6.  Histone deacetylase inhibitors induce complex host responses that contribute to differential potencies of these compounds in HIV reactivation.

Authors:  Nadejda Beliakova-Bethell; Amey Mukim; Cory H White; Savitha Deshmukh; Hosiana Abewe; Douglas D Richman; Celsa A Spina
Journal:  J Biol Chem       Date:  2019-02-11       Impact factor: 5.157

7.  Epothilone B enhances surface EpCAM expression in ovarian cancer Hey cells.

Authors:  Shohreh Shahabi; Chia-Ping Huang Yang; Gary L Goldberg; Susan Band Horwitz
Journal:  Gynecol Oncol       Date:  2010-08-02       Impact factor: 5.482

8.  Benzyl isothiocyanate-mediated inhibition of histone deacetylase leads to NF-kappaB turnoff in human pancreatic carcinoma cells.

Authors:  Sanjay Batra; Ravi P Sahu; Prabodh K Kandala; Sanjay K Srivastava
Journal:  Mol Cancer Ther       Date:  2010-05-18       Impact factor: 6.261

9.  Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21(Waf1/Cip1).

Authors:  Ying Zhao; Shaoli Lu; Lipeng Wu; Guolin Chai; Haiying Wang; Yingqi Chen; Jia Sun; Yu Yu; Wen Zhou; Quanhui Zheng; Mian Wu; Gregory A Otterson; Wei-Guo Zhu
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

10.  Coordinated posttranscriptional mRNA population dynamics during T-cell activation.

Authors:  Neelanjan Mukherjee; Patrick J Lager; Matthew B Friedersdorf; Marshall A Thompson; Jack D Keene
Journal:  Mol Syst Biol       Date:  2009-07-28       Impact factor: 11.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.